Vaccines, funding reforms and improving equity in medical research with NHMRC CEO Professor Steve Wesselingh
Listen now
Description
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Professor Steve Wesselingh, CEO of the National Health and Medical Research Council (NHMRC). An infectious disease physician and researcher in HIV vaccine development and the impact of the microbiome on human health, Steve has a wealth of medical experience, clinical leadership, and national and international success.   The NHMRC is Australia's lead agency, driving innovative health and medical research to improve the health of all Australians.  Along with providing an ethical framework for health and medical research in our country, the NHMRC supports the discovery of new knowledge and its translation into public health, health services and medical products to improve health outcomes for all Australians. In this episode you will hear about: Steve’s journey to becoming one of the world’s leading HIV researchers.The influence international experience in the US and Papua New Guinea had on his careerFunding opportunities that could help Australia improve med tech or clinical outcomesSteve’s priorities as CEO of the NHMRC over the next 24 months and beyond, including government strategy input, and working more closely with the Australian Centre for Disease Control (CDC)Learn more about Professor Steve Wesselingh  Read more about the NHMRC.   Updated version 05/08/22
More Episodes
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Stephen Tomisich, Co-founder and CEO of Trajan Scientific and Medical.    Based in Melbourne, Trajan develops and manufactures analytical science instruments, devices and solutions for health care, as well as for food and...
Published 04/15/24
Published 04/15/24
In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Chris Smith, a partner at Brandon Capital - Australasia's leading life science venture capital firm. Chris has extensive experience in the global biotech industry. With a PhD in immunology and an MBA specialising in...
Published 03/12/24